Hope Center
Terre Haute, Indiana 47809
0 studies enrolling now · 17 studies all time
What they study most
Androgen-independent Prostate Cancer, B-Cell Chronic Lymphocytic Leukemia, Breast Cancer, Colorectal Cancer, Gastric Cancer Adenocarcinoma Metastatic, Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Prostate Cancer
Studies at this site
- TAC Versus TC for Adjuvant Breast Cancer — Completed
- A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed
- AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy — Completed
- Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer — Completed
- Phase II Sunitinib Prog Met AIPC — Completed
- Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
- Docetaxel+Oxali+/-Cetux Met Gastric/GEJ — Completed
- Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients — Completed
- Adj TC + Herceptin Early Stage Breast Cancer — Completed
- Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed
- Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma — Stopped early
- Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
- Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer — Completed
- Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer — Completed
- Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
- Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. — Completed
- DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early